#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mycobacterium abscessus infection Bone marrow disorder PIK3CA related overgrowth spectrum Diffuse large B-cell lymphoma refractory Waldenstrom's macroglobulinaemia refractory Hodgkin's disease refractory Infertility male Astrocytoma Cutaneous T-cell lymphoma refractory Hypoparathyroidism Breast cancer Pleomorphic leiomyosarcoma Spinal cord injury Chordoma Epidermolysis bullosa More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Life with Disease Adrenogenital syndrome – Diagnostics Erdheim-Chester disease – Life with Disease Breast angiosarcoma metastatic – Diagnostics CADASIL – Basic Information Marfan’s syndrome – Trials in Disease Friedreich’s ataxia – Treatment Anaplastic thyroid cancer – Basic Information Pulmonary fibrosis – Trials in Disease Pulmonary fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abelacimab Stx-241 Oxcarbazepine GSKVX000000025896 Estradiol Hemihydrate Verapamil Hydrochloride Ecoo2 Ketamine Tabelecleucel Pralsetinib Clomifene Citrate Abiraterone Acetate Poa Pratensis Pollen Extract Tazobactam GSKVX000000048111 Epinephrine Regtivex LIGUFALIMAB Avelumab Folinic Acid More therapies…

    Learn about Your Condition

    Pemphigoid Cytokine release syndrome Mixed-type liposarcoma Paraganglion neoplasm Chronic hepatic failure Merycism Aortic valve disease Agitation postoperative Torticollis Biliary tract disorder Gallbladder cancer Congenital aplastic anaemia CADASIL Fibromyalgia Iron deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Pegcetacoplan
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on Elamipretide for Patients with Dry Age-Related Macular Degeneration (Dry AMD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    Czechia Germany Hungary Italy Spain

  • Study of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    Austria

  • Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Bulgaria France Germany Italy Latvia +4

  • Study of Efgartigimod for Adults with Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Estonia Germany Greece +4

  • Preventing Neovascular Glaucoma in Patients with Large Choroidal Melanoma Using Aflibercept During Proton Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Choroid melanoma
    Investigated Drugs:
    • Aflibercept
    France
Previous Page
1 … 23 24 25 26 27 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!